Literature DB >> 2844985

Peripheral blood mononuclear cell-mediated cytolytic activity during cytomegalovirus (CMV) infection of guinea pigs.

C J Harrison1, M G Myers.   

Abstract

Inbred Strain-2 guinea pigs exhibited endogenous peripheral blood mononuclear cell (PBMC)-mediated cytolytic activity against xenogeneic MA104 targets and guinea pig cytomegalovirus (gpCMV)-infected syngeneic and allogeneic targets. This endogenous cytolysis was unaffected by monoclonal T-cell antibody depletion but was diminished by removal of plastic adherent cells. In nonadherent effector populations, cytolysis was mediated predominately by large granular lymphocytes (LGL). During gpCMV infection, cytolysis of both target types was augmented (MA 104 for 3 weeks and gpCMV targets for 10-14 weeks). Augmented cytolysis of gpCMV targets was MHC-unrestricted and was diminished by removal of plastic adherent cells or monoclonal antibody depletion of T-cells, being found largely in LGL enriched populations. A role for this augmented activity in limiting gpCMV infection in inbred guinea pigs is suggested by the temporal association of augmented cytolysis of gpCMV targets with the cessation of viremia and clinical recovery.

Entities:  

Mesh:

Year:  1988        PMID: 2844985     DOI: 10.1002/jmv.1890250408

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Natural killer and lectin-dependent cytotoxic activities of Kurloff cells: target cell selectivity, conjugate formation, and Ca++ dependency.

Authors:  N Pouliot; K Maghni; F Blanchette; L Cironi; P Sirois; J Stankova; M Rola-Pleszczynski
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

2.  Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs.

Authors:  C J Harrison; R L Miller; D I Bernstein
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.